Abbott Laboratories v. Gardner
Abbott Laboratories v. Gardner, 387 U.S. 136 (1967), was a case heard before the United States Supreme Court. Abbott Laboratories held that drug companies were not prohibited by the ripeness doctrine from challenging a U.S. Food and Drug Administration (FDA) regulation requiring a prescription drug's generic name to appear on all related printed materials. The government argued that the case was not ripe because the regulation had yet to be enforced; however, that argument failed as the Court found the issues to be fit for judicial resolution, and that the drug companies would experience substantial hardship if denied a pre-enforcement challenge to the statute. Prosecution for non-compliance was likely, civil and criminal penalties could be imposed, and the drug companies would suffer repu
Wikipage redirect
primaryTopic
Abbott Laboratories v. Gardner
Abbott Laboratories v. Gardner, 387 U.S. 136 (1967), was a case heard before the United States Supreme Court. Abbott Laboratories held that drug companies were not prohibited by the ripeness doctrine from challenging a U.S. Food and Drug Administration (FDA) regulation requiring a prescription drug's generic name to appear on all related printed materials. The government argued that the case was not ripe because the regulation had yet to be enforced; however, that argument failed as the Court found the issues to be fit for judicial resolution, and that the drug companies would experience substantial hardship if denied a pre-enforcement challenge to the statute. Prosecution for non-compliance was likely, civil and criminal penalties could be imposed, and the drug companies would suffer repu
has abstract
Abbott Laboratories v. Gardner ...... efore challenging it in court.
@en
Link from a Wikipage to an external page
Wikipage page ID
10,824,194
Wikipage revision ID
742,207,645
ArgueDate
ArgueYear
case
Abbott Laboratories v. Gardner, 387 U.S. 136
citation
DecideDate
DecideYear
Dissent
findlaw
http://laws.findlaw.com/us/387/136.html
Holding
Drug companies were not prohib ...... all related printed materials.
JoinDissent
JoinMajority
Black, Douglas, Stewart, White
justia
LawsApplied
Litigants
Abbott Laboratories v. Gardner
majority
NotParticipating
SCOTUS
subject
comment
Abbott Laboratories v. Gardner ...... ug companies would suffer repu
@en
label
Abbott Laboratories v. Gardner
@en
wasDerivedFrom
isPrimaryTopicOf
name
Abbott Laboratories, et al. v. ...... Education, and Welfare, et al.
@en